These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Lue H; Dewor M; Leng L; Bucala R; Bernhagen J Cell Signal; 2011 Jan; 23(1):135-44. PubMed ID: 20807568 [TBL] [Abstract][Full Text] [Related]
10. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Bernhagen J; Krohn R; Lue H; Gregory JL; Zernecke A; Koenen RR; Dewor M; Georgiev I; Schober A; Leng L; Kooistra T; Fingerle-Rowson G; Ghezzi P; Kleemann R; McColl SR; Bucala R; Hickey MJ; Weber C Nat Med; 2007 May; 13(5):587-96. PubMed ID: 17435771 [TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors. Lourenco S; Teixeira VH; Kalber T; Jose RJ; Floto RA; Janes SM J Immunol; 2015 Apr; 194(7):3463-74. PubMed ID: 25712213 [TBL] [Abstract][Full Text] [Related]
12. CD74 is a functional MIF receptor on activated CD4 Zhang L; Woltering I; Holzner M; Brandhofer M; Schaefer CC; Bushati G; Ebert S; Yang B; Muenchhoff M; Hellmuth JC; Scherer C; Wichmann C; Effinger D; Hübner M; El Bounkari O; Scheiermann P; Bernhagen J; Hoffmann A Cell Mol Life Sci; 2024 Jul; 81(1):296. PubMed ID: 38992165 [TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway. Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873 [TBL] [Abstract][Full Text] [Related]
14. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex. Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495 [TBL] [Abstract][Full Text] [Related]
15. Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects. Benedek G; Meza-Romero R; Andrew S; Leng L; Burrows GG; Bourdette D; Offner H; Bucala R; Vandenbark AA Eur J Immunol; 2013 May; 43(5):1309-21. PubMed ID: 23576302 [TBL] [Abstract][Full Text] [Related]
16. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells. DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961 [TBL] [Abstract][Full Text] [Related]
17. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer. Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658 [TBL] [Abstract][Full Text] [Related]
18. A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide. Lapter S; Ben-David H; Sharabi A; Zinger H; Telerman A; Gordin M; Leng L; Bucala R; Shachar I; Mozes E Immunology; 2011 Jan; 132(1):87-95. PubMed ID: 20738420 [TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731 [TBL] [Abstract][Full Text] [Related]